5:08 PM
 | 
May 25, 2016
 |  BC Extra  |  Financial News

Arrivo debuts with $49M

Newco Arrivo BioVentures LLC (Research Triangle Park, N.C.) launched with a $49 million venture round led by Jazz Pharmaceuticals plc (NASDAQ:JAZZ). Solas BioVentures, Rex Health Ventures and undisclosed others also participated.

Arrivo plans to acquire or in-license four to six candidates that are in or ready...

Read the full 225 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >